arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Sanofi

SNY Health Care Biotechnology: Pharmaceutical Preparations
$42.79
▲ +0.0% Today
as of Aug 5, 16:54 ET
Last 30 days -0.40% Jun 26 → Aug 05
$41.32 $42.45 $43.59 $44.72 $45.85 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$45.00
High
$45.24
Low
$44.83
Volume
$2M
Avg Vol
$3M
Mkt Cap
$104.6B
P/E (TTM)
—
Beta
—
52w High
$52.68
52w Low
$42.28
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 3 ● 22 ▼ 0
Aug 4 · 16:08 REGULATORY MT Newswires neutral
Nurix Therapeutics Gets $10 Million Milestone Payment as Sanofi Initiates Phase 1 Trial of STAT6 Degrader
Aug 4 · 08:20 MT Newswires neutral
Sanofi Says EU Expands MenQuadfi Approval
Aug 4 · 05:00 PR GlobeNewswire neutral
Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$42
$53
5% of range
Avg surprise (last 2)
-0.9%
Avg reaction (last 1)
+1.0%
100% positive
Latest IV / EM
26%
EM ±4.3% · $43 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.40$0.67$0.93$1.20$1.46 Actual $0.94Est $0.90Actual $0.90Est $0.96 Mar/2025Jun/2025

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Jul 31, 2025Jun/2025 $0.90 $0.96 -6.2% — — earnings
Thu Apr 24, 2025Mar/2025 $0.94 $0.90 +4.4% — +1.0% earnings

Implied volatility — last 90 days

20%37%55%72%89% Jun 07 — IV 26% · EM ±3.7%Jun 08 — IV 47% · EM ±6.3%Jun 09 — IV 26% · EM ±3.2%Jun 10 — IV 34% · EM ±4.0%Jun 11 — IV 30% · EM ±3.3%Jun 12 — IV 25% · EM ±2.6%Jun 15 — IV 44% · EM ±3.2%Jun 16 — IV 81% · EM ±4.8%Jun 17 — IV 28% · EM ±1.2%Jun 19 — IV 24% · EM ±5.3%Jun 22 — IV 24% · EM ±5.0%Jun 23 — IV 26% · EM ±5.2%Jun 24 — IV 24% · EM ±4.9%Jun 25 — IV 23% · EM ±4.6%Jun 26 — IV 24% · EM ±4.5%Jun 29 — IV 24% · EM ±4.3%Jun 30 — IV 24% · EM ±4.1%Jul 01 — IV 23% · EM ±3.8%Jul 02 — IV 21% · EM ±3.4%Jul 03 — IV 22% · EM ±3.4%Jul 06 — IV 28% · EM ±3.9%Jul 07 — IV 29% · EM ±3.8%Jul 08 — IV 25% · EM ±3.2%Jul 09 — IV 35% · EM ±4.2%Jul 10 — IV 35% · EM ±3.9%Jul 13 — IV 37% · EM ±3.1%Jul 14 — IV 38% · EM ±2.8%Jul 15 — IV 53% · EM ±3.1%Jul 16 — IV 89% · EM ±3.7%Jul 20 — IV 31% · EM ±7.3%Jul 21 — IV 33% · EM ±7.6%Jul 22 — IV 32% · EM ±7.4%Jul 23 — IV 32% · EM ±7.2%Jul 24 — IV 31% · EM ±6.8%Jul 27 — IV 32% · EM ±6.7%Jul 28 — IV 32% · EM ±6.5%Jul 29 — IV 28% · EM ±5.7%Jul 30 — IV 27% · EM ±5.2%Jul 31 — IV 25% · EM ±4.8%Aug 03 — IV 26% · EM ±4.7%Aug 04 — IV 26% · EM ±4.6%Aug 05 — IV 26% · EM ±4.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in